Age-specific FSH levels as a tool for appropriate patient counselling in assisted reproduction
|
|
- Joshua Garrett
- 6 years ago
- Views:
Transcription
1 Human Reproduction Vol.20, No.9 pp , 2005 Advance Access publication May 19, 2005 doi: /humrep/dei076 Age-specific FSH levels as a tool for appropriate patient counselling in assisted reproduction Andrea Weghofer 1,3, Markus Margreiter 1, Yvonne Fauster 2, Theresa Schaetz 2, Agnes Brandstetter 2, Doris Boehm 2 and Wilfried Feichtinger 1 1 Wunschbabyzentrum-Institute for Sterility Treatment, A-1130 Vienna and 2 Medical University Vienna, A-1090 Vienna, Austria 3 To whom correspondence should be addressed. aweghofer@gmx.at BACKGROUND: The purpose of this study was to assess whether, even within a normal FSH range (#10 mu/ml), age-specific FSH levels are predictive of ovarian reserve. METHODS: Between January 1998 and December 2001, 535 women, undergoing controlled ovarian stimulation with 225 IU of recombinant (rec) FSH and 75 IU of reclh, were included in this retrospective cohort study. Criteria for enrolment were: age years, basal FSH (b-fsh) #10 mu/ml and basal LH #12 mu/ml. Patients were assigned to three age groups (group I: years; group II: years; and group III: years). Each age group was divided into quartiles according to b-fsh levels, comparing the lowest and highest b-fsh quartiles for basal hormonal patterns and outcome-related parameters. RESULTS: At ages years, women in the lowest FSH quartiles demonstrated significantly increased numbers of oocytes at retrieval (group I: low b-fsh quartile versus high b-fsh quartile , P<0.02; group II: versus , P<0.047), whereas no difference with regard to oocyte yield was observed in patients above age 35 (group III: low b-fsh quartile versus high b-fsh quartile ). No statistical correlation was found between FSH quartiles and clinical pregnancy rates or miscarriage. CONCLUSIONS: In young women, age-specific high b-fsh levels, even within normal ranges, are associated with significantly reduced numbers of oocytes retrieved. B-FSH concentrations should, therefore, be interpreted in an age-specific manner to allow for appropriate patient counselling in IVF. Key words: age/fsh/ivf/ovarian reserve/poor responder Introduction The success of IVF is critically dependent on the appropriate evaluation of ovarian function to optimize controlled ovarian stimulation (COS). While follicular depletion and impaired oocyte quality, frequently also called diminished ovarian reserve (Kligman and Rosenwaks, 2001; Bancsi et al., 2002; Chuang et al., 2003), are generally acknowledged as the underlying mechanisms for the decline in maternal fecundity, the way to assess the status of ovarian reserve correctly has remained controversial (Fanchin et al., 1994; Lambalk, 2003). The association between advanced female age and reproductive senescence is well established (Oosterhuis et al., 2002; Jansen, 2003). Nevertheless, in women of the same age, individual variations exist with regard to their ovarian responses (Pellicer et al., 1998; Perez et al., 2000). Chronological female age is universally seen as indicative of qualitative alterations of the remaining follicle pool (Popovic-Todorovic et al., 2003; Toner, 2003; Van Rooij et al., 2003,2004a), but cannot serve as the sole marker of ovarian status (Kligman and Rosenwaks, 2001). A variety of tests, such as the antral follicle count, the clomiphene challenge test and measurements of basal inhibin B (Mukherjee et al., 1996; Creus et al., 2000; Fasouliotis et al., 2000; Meo et al., 2002), have been introduced as predictive of ovarian reserve; however, cycle day 2 or 3 FSH, i.e. basal (b-)fsh, is still the most widely used parameter in the assessment of ovarian function (Tanbo et al., 1992; Letur-Konirsch and Guis, 1996; Bancsi et al., 2003; Smits et al., 2003). Recently, some controversy has arisen about the clinical utility of b-fsh measurements (Jurema et al., 2003; Scott, 2004; Toner, 2004; Wolff and Taylor, 2004). Abdalla and Thum (2004), as well as Van Rooij et al. (2004b), depicted reduced, yet still clinically sound pregnancy and live birth rates in young women with elevated b-fsh levels of up to 20 mu/ml. They, therefore, concluded that the predictive value of b-fsh concentrations should be restricted to the counselling of patients on the probability of achieving pregnancy, but should not be used to exclude them from fertility treatment. Scott (2004) goes even further, denying any predictive value to b-fsh concentrations within normal ranges. In contrast, Jurema et al. (2003) describe substantially reduced cut off-levels for b-fsh values (, 6 IU/l) to predict ovarian response to stimulation accurately, but agree that they do not predict pregnancy potential. They also argue, 2448 q The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please journals.permissions@oupjournals.org
2 Age-specific FSH as a predictor of ovarian reserve however, that b-fsh cut off-values of up to 10 IU/l will include virtually all pregnancies in a cohort with normal prognosis. Though contradictory opinions exist regarding the appropriate cut-off level for b-fsh values in the evaluation of ovarian reserve, so far there has been unanimity about interpreting b-fsh levels in absolute (i.e. fixed) terms. Since a majority of hormonal test results is subject to age-related alterations (El-Touky et al., 2002) and since ovarian reserve is known to decline in an age-dependent manner (Bancsi et al., 2003), age-specific interpretations of b-fsh values might result in a more accurate assessment of ovarian function. The study presented here, therefore, was initiated to evaluate the impact of age-specific b-fsh concentrations on ovarian response in young women with normal b-fsh levels (#10 mu/ml). Patients and methods Study design and patients Five-hundred and thirty-five regular cycling women, aged years, undergoing their first cycle of COS between January 1998 and December 2001, were included in this retrospective cohort study. Only cycles using a combination of clomiphene citrate and gonadotrophins for ovarian stimulation were eligible for enrolment. Patients suspected of having polycystic ovary syndrome were excluded from the analysis. Cut-off values for b-fsh and LH levels, measured on cycle days 2 or 3, immediately before the commencement of oral contraception, were considered as follows: b-fsh # 10 mu/ml and b-lh #12 mu/ml. Based on age, patients were assigned to the following three groups: group I: age years; group II: age years; and group III: age years. Each age group, in turn, was divided into quartiles according to b-fsh levels. Within each age group, the lowest and highest b-fsh quartiles were compared for the following parameters: female chronological age, treatment indications, b-lh and b-estradiol (E 2 ) levels, smoking status, number of oocytes retrieved, day of embryo transfer, number of embryos transferred, miscarriage and clinical pregnancy rates. A maximum of four oocytes at oocyte retrieval was considered poor ovarian response. To assess the impact of chronological female age, b-fsh level and smoking on oocyte yield within and between age groups, both a univariate and a multivariate analysis of variance (ANOVA) were performed, including the following parameters: chronological age (group I, II and III), b-fsh level (low and high b-fsh quartiles) and smoking. Furthermore, the interaction for age low b-fsh and for age high b-fsh was calculated. Ovarian stimulation and fertilization After pre-treatment with oral contraceptives (18 28 days), COS was initiated with clomiphene citrate (daily dose of 100 mg per os on cycle days 1 5) and a combination of 225 IU of recombinant (rec) FSH and 75 IU of reclh on alternate days, i.e. on cycle day 1, 3, 5 and 7 (Weigert et al., 2002). To allow for easy handling and to warrant a fixed ratio of gonadotrophins, no dosage adjustments were performed. In the case of inadequate follicular response, i.e. leading follicle diameter,18 mm after 7 days of stimulation, an additional dosage of 225 IU of recfsh and 75 IU of reclh was given on cycle day 9. Cycle monitoring, oocyte retrieval and embryo transfer were performed in a routine fashion, as previously reported (Margreiter et al., 2003). A clinical pregnancy was defined as the presence of fetal cardiac activity beyond 8 weeks of gestation. Institutional review board (IRB) approval Since the present study was based on a retrospective data analysis, no IRB approval was required. Statistical analysis The present data analysis was performed with the Statistics Package for Social Sciences (SPSS, Chicago, IL). Differences in baseline characteristics and outcome measures within and between age groups and b-fsh subsets of patients were investigated by ANOVA. Furthermore, the interaction between b-fsh (two groups: low and high b-fsh quartiles) and age (three groups: groups I III) was assessed using ANOVA. Descriptive results are presented as means with SD. s, 0.05 were considered statistically significant. Results Indications for fertility treatment and patients characteristics are presented in Tables I and II. The mean age of the women eligible for enrolment in group I was 27.5 ^ 1.2 years in the lowest b-fsh quartile and 27.8 ^ 1.2 years in the highest b-fsh quartile. In patients allocated to group II, the mean age was 32.6 ^ 1.5 in the lowest b-fsh quartile and 32.6 ^ 1.6 years in the highest b-fsh quartile, whereas women in group III were aged on average 37.5 ^ 1.4 years Table I. Indications for fertility treatment according to patients age and basal (b-)fsh levels (n = 114) a b a b a (n = 34) b Male factor 28 (70.0%) 15 (50.0%) 46 (67.6%) 33 (50.8%) 19 (55.9%) 17 (51.5%) Tubal factor 3 (7.5%) 8 (26.7%) 14 (20.6%) 21 (32.3%) 8 (23.5%) 10 (30.3%) Combined factors 2 (5.0%) 1 (3.3%) 3 (4.4%) 2 (3.1%) 0 2 (6.1%) Endometriosis 4 (10.0%) 3 (10.0%) 1 (1.5%) 2 (3.1%) 1 (2.9%) 2 (6.1%) Immunological infertility (5.9%) 0 Unexplained infertility 3 (7.5%) 3 (10.0%) 4 (5.9%) 7 (10.8%) 4 (11.8%) 2 (6.1%) a = lowest b-fsh quartile of the age group. b = highest b-fsh quartile of the age group. 2449
3 A.Weghofer et al. Table II. Patients characteristics according to female age and serum b-fsh levels (n = 114) (nthinsp; = 34) Age (years) 27.5 ^ ^ 1.2 NS 32.6 ^ ^ 1.6 NS 37.5 ^ ^ 1.5 NS b-fsh (mu/ml) 5.9 ^ ^ ^ ^ ^ ^ ^ ^ ^ 0.6 b-lh (mu/ml) 2.6 ^ ^ ^ ^ ^ ^ Estradiol (pg/ml) 19.5 ^ ^ 20.7 NS 20.4 ^ ^ 23.9 NS 20.2 ^ ^ Smoking status a 25.0% 26.7% NS 26.5% 38.4% % 39.4% NS a Statistical analysis for confounding of smoking did not reveal a significant effect on oocyte yield, either in univariate or in multivariate analysis. (lowest b-fsh quartile) and 37.5 ^ 1.5 years (highest b-fsh quartile), respectively. Age groups and FSH quartiles were similar with regard to cycle length. Within all age groups, women in the highest b-fsh quartiles showed significantly higher b-lh levels than patients in the lowest b-fsh quartiles. The correlation coefficients between b-fsh and b-lh for low versus high FSH quartiles were as follows: group I: 0.57 versus 0.14; group II: 0.42 versus 0.18; and group III: 0.32 versus At ages 36 40, women in the highest b-fsh quartile also demonstrated statistically elevated b-e 2 levels, whereas younger women showed no differences in E 2 levels between the various FSH quartiles. The impact of chronological female age and b-fsh level on oocyte yield was assessed further by univariate as well as by multivariate ANOVA. A significant influence on the number of oocytes retrieved was found for female chronological age (univariate, P, 0.001; multivariate, P = 0.039) and for age-specific high b-fsh levels (univariate, P, 0.003; multivariate, P = 0.027). To assess the impact of smoking on oocyte yield, univariate and multivariate ANOVA was performed. Smoking did not, however, have a significant impact on oocyte yield in our patient cohort (univariate analysis, P = 0.44; multivariate analysis, P = 0.56). Outcome-related parameters are summarized in Table III. Women aged years, in the lowest quartile of b-fsh levels, demonstrated significantly increased numbers of oocytes at retrieval (number of oocytes retrieved in group I, low b-fsh quartile, 8.4 ^ 3.7 versus high b-fsh quartile, 6.4 ^ 2.7, P, 0.02; group II, low b-fsh quartile, 7.5 ^ 4.0 versus high b-fsh quartile, 6.3 ^ 3.0, P, 0.047), whereas no difference with regard to oocyte yield was observed in patients above age 35 (group III, low b-fsh quartile, 5.5 ^ 3.1 versus high b-fsh quartile, 5.6 ^ 3.5, not significant). To assess further the impact of b-fsh and chronological age on oocyte yield, an interaction with main effects for age (groups I III) and b-fsh (low and high b-fsh) was performed. However, neither the interaction of low b-fsh levels and age (groups I III), nor the interaction of high b-fsh levels and age (groups I III) demonstrated significant results (low b-fsh age, P = 0.2; high b-fsh age, P = 0.6). No statistical correlation was found between clinical pregnancy rates and miscarriage to b-fsh levels Discussion A normal b-fsh level (# 10 mu/ml) and young chronological age (#35 years) are generally acknowledged as the two most promising prognostic factors, reflecting ovarian function, in women initiating fertility treatment (Jurema et al., 2003; Van Rooij et al., 2003). Such patients will, therefore, usually receive age-specific, and as mild as possible, stimulation protocols. Our study, however, clearly demonstrates that in women, aged years, b-fsh levels, even within a normal range, matter with regard to oocyte numbers. Higher age-specific FSH levels lead to fewer eggs (Figure 1). The lack of significance of the interaction between b-fsh and age supports these findings. In contrast, in women of advanced reproductive age (.35 years), the variations of b-fsh levels, as long as they are still,10.1 mu/ml, are not predictive of oocyte yield. The significant increase in b-e 2 levels in patients above age 35 with age-specific high FSH values can, though, be interpreted as reflective of diminishing ovarian reserve (Larsen et al., 2003; Tarlatzis et al., 2003; Gurbuz et al., 2004). Within our data analysis, a correlation between b-fsh and b-lh was observed in all women; patients in the highest FSH quartiles showed significantly higher LH levels than women with low age-specific FSH values. These findings might be attributable to an increasing sensitivity of the pituitary to GnRH with imminent ovarian failure, as previously reported by de Koning et al. (2000). Variations in b-fsh levels are also not predictive of clinical pregnancy and miscarriage rates. This finding should not be a surprise because, as long as patients are still capable of producing a minimal number of oocytes of acceptable quality, they will also produce adequate numbers of good quality embryos for a single embryo transfer. Consequently, high b-fsh levels, especially in young patients, should not serve as exclusion criteria from fertility treatment, but as a guidance to individual patient counselling. Large differences in pregnancy (and miscarriage) rates should become statistically visible only if the outcomes of frozen thawed embryo transfer cycles (FETs) are added in producing cumulative pregnancy rates from single retrievals. This was recently also confirmed by Gleicher et al. (personal communication) who in. 60 women with proven ovarian resistance, all below age 35, demonstrated ongoing
4 Age-specific FSH as a predictor of ovarian reserve Table III. Cycle outcomes according to female age and serum b-fsh levels (n = 144) (n = 34) No. of oocytes retrieved 8.4 ^ 3.7 (1 17) 6.4 ^ 2.7 (1 13) ^ 4.0 (1 19) 6.3 ^ 3.0 (1 15) ^ 3.1 (1 14) 5.6 ^ 3.5 (1 13) NS No. of oocyte retrievals with.4 oocytes 33 (82.5%) 24 (80%) NS 56 (82.4%) 47 (72.3%) NS 18 (52.9%) 17 (51.5%) NS No. of cycles cancelled 1 (2.5%) 2 (6.7%) NS 2 (2.9%) 1 (1.5%) NS 2 (5.9%) 3 (9.1%) NS No. of embryos transferred 2.0 ^ 0.3 (1 3) 2.0 ^ 0.5 (1 3) NS 2.3 ^ 0.6 (1 3) 2.2 ^ 0.6 (1 3) NS 2.4 ^ 0.7 (1 3) 2.1 ^ 0.6 (1 3) NS Day of embryo transfer 3.0 ^ 0.9 (2 5) 2.7 ^ 0.7 (2 4) NS. 3.1 ^ 0.9 (2 5) 2.8 ^ 0.9 (1 5) NS 3.0 ^ 0.9 (1 5) 2.6 ^ 1.0 NS Miscarriage 3 (7.5%) 6 (20%) n.s. 6 (8.8%) 3 (4.6%) NS 3 (8.8%) 4 (12.1%) NS Clinical pregnancy rate 6 (15%) 6 (20%) n.s. 18 (26.5%) 18 (27.7%) NS 6 (17.6%) 8 (24.2%) NS Figure 1. Number of oocytes retrieved according to female age and serum FSH levels. Women are allocated to groups according to chronological age; each age group is subdivided into FSH quartiles (grey, lowest FSH quartile of age group; black, highest FSH quartile of age group). Mean basal FSH (b-fsh) levels according to age groups: group I, 3.2 ^ 1.5 mu/ml in the lowest FSH quartile versus 8.8 ^ 0.7 mu/ml in the highest FSH quartile; group II, 3.3 ^ 1.4 versus 8.9 ^ 0.6 mu/ml; group III, 3.0 ^ 1.5 versus 9.0 ^ 0.6 mu/ml. pregnancy rates identical to those in matched controls with normal ovarian function. However, when cumulative pregnancy rates, indicating potential FET results, were calculated, control patients, indeed, demonstrated significantly higher pregnancy rates due to their larger oocyte numbers at the time of retrieval. Our results also coincide with those of Jurema et al. (2003) who also, at normal b-fsh levels, were unable to detect an impact on pregnancy rates in IVF cycles. Wolff and Taylor (2004) recently suggested that patients with elevated b-fsh levels should not be excluded from IVF treatment. Instead, these authors presented (in intriguing analogy to current prenatal genetic screening) that b-fsh values, among other parameters, such as chronological age and follicular phase inhibin B, should be utilized to establish an age-specific likelihood ratio for ovarian response. In conclusion, the present study demonstrates that, at young ages, b-fsh, even if within normal ranges, may contribute to the prediction of ovarian reserve, as a reflection of the number of oocytes retrieved. Consequently, b-fsh should not serve as a marker to exclude patients from fertility treatment, but should be interpreted according to patient s age and not in absolute terms, even within the generally considered normal range of # 10 mu/ml. An age-specific definition of ovarian reserve will allow physicians to stimulate patients in a more individualized fashion, which, in turn, will maximize IVF outcomes. Acknowledgements The authors thank Professor Dr Werner Brannath for his invaluable assistance with data analysis. References Abdalla H and Thum MY (2004) An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Hum Reprod 19,
5 A.Weghofer et al. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD and Te Velde ER (2002) Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 77, Bancsi LF, Broekmans FJ, Mol BW, Habbema JD and te Velde ER (2003) Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil Steril 79, Chuang CC, Chen CD, Chao KH, Chen SU, Ho HN and Yang YS (2003) Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization. Fertil Steril 79, Creus M, Penarrubia J, Fabregues F, Vidal E, Carmona F, Casamitjana R, Vanrell JA and Balasch J (2000) Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 15, de Koning CH, Popp-Snijders C, Schoemaker J and Lambalk CB (2000) Elevated FSH concentrations in imminent ovarian failure are associated with higher FSH and LH pulse amplitude and response to GnRH. Hum Reprod 15, El-Toukhy T, Khalaf Y, Hart R, Taylor A and Braude P (2002) Young age does not protect against the adverse effects of reduced ovarian reserve an eight year study. Hum Reprod 17, Fanchin R, de Ziegler D, Oliviennes F, Taieb J, Dzik A and Frydman R (1994) Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting poor responders in in-vitro fertilization. Hum Reprod 9, Fasouliotis SJ, Simon A and Laufer N (2000) Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet. J Assist Reprod Genet 17, Gurbuz B, Yalti S, Ozden S and Ficicioglu C (2004) High basal estradiol level and FSH/LH ratio in unexplained recurrent pregnancy loss. Arch Gynecol Obstet 270, Jansen RP (2003) The effect of female age on the likelihood of a live birth from one in-vitro ferilization treatment. Med J Aust 178, Kligman I and Rosenwaks Z (2001) Differentiating clinical profiles: predicting good responders, poor responders, and hyperresponders. Fertil Steril 76, Jurema MW, Bracero NJ and Garcia JE (2003) Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles. Fertil Steril 80, Lambalk CB (2003) Value of elevated basal follicle-stimulating hormone levels and the differential diagnosis during the diagnostic subfertility work-up. Fertil Steril 79, Larsen EC, Muller J, Schmiegelow K, Rechnitzer C and Anderson AN (2003) Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 88, Letur-Konirsch H and Guis F (1996) Recovery of ovarian function after radiation-induced menopause. Does follicle-stimulating hormone (FSH) have a definitive prognostic value? CR Acad Sci III 319, Margreiter M, Weghofer A, Kogosowski A, Mahmoud KZ and Feichtinger W (2003) A prospective randomized multicenter study to evaluate the best day for embryo transfer. Does the outcome justify prolonged culture? J Assist Reprod Genet 20, Meo F, Ranieri DM, Khadum I and Serhal P (2002) Ovarian response and in vitro fertilization outcome in patients with reduced ovarian reserve who were stimulated with recombinant follicle-stimulating hormone or human menopausal gonadotropin. Fertil Steril 17, Mukherjee T, Copperman AB, Lapinski R, Sandler B, Bustillo M and L (1996) An elevated day three follicle-stimulating hormone: luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril 65, Oosterhuis GJ, Vermes I, Michgelsen HW, Schoemaker J and Lambalk CB (2002) Follicle stimulating hormone measured in unextracted urine throughout the menstrual cycle correlates with age and ovarian reserve. Hum Reprod 17, Pellicer A, Ardiles G, Neuspiller F, Remohi J, Simon C and Bonilla- Musoles F (1998) Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography. Fertil Steril 70, Perez MM, Gromoll J, Behre HM, Gassner C, Nieschlag E and Simoni M (2000) Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 85, Popovic-Todorovic B, Loft A, Lindhard A, Bangsboll S, Andersson AM and Andersen AN (2003) A prospective study of predictive factors of ovarian response in standard IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram. Hum Reprod 18, Scott RT (2004) Diminished ovarian reserve and access to care. Fertil Steril 81, Smits G, Olatunbosun MB, Delbaere A, Pierson R, Vassart G and Costagliola S (2003) Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med 349, Tanbo T, Dale PO, Lunde O, Norman N and Abyholm T (1992) Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels. Fertil Steril 57, Tarlatzis BC, Zepiridis L, Grimbizis G and Bontis J (2003) Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 9, Toner JP (2004) Modest follicle-stimulating hormone elevations in younger women: warn but don t disqualify. Fertil Steril 81, Toner JP (2003) Age = egg quality, FSH level = egg quantity. Fertil Steril 79,491. Van Rooij IA, Bancsi LF, Broekmans FJ, Looman CW, Habbema JD and te Velde ER (2003) Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril 79, Van Rooij IA, De Jong E, Broekmans FJ, Looman CW, Habbema JD and Te Velde ER (2004a) The limited value of follicle-stimulating hormone as a test for ovarian reserve. Fertil Steril 81, Van Rooij IA, de Jong E, Broekmans FJ, Looman CW, Habbema JD and te Velde ER (2004b) High follicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment. Fertil Steril 81, Weigert M, Krischker U, Pohl M, Poschalko G, Kindermann C and Feichtinger W (2002) Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study. Fertil Steril 78, Wolff EF and Taylor HS (2004) Value of the day 3 follicle-stimulating hormone measurement. Fertil Steril 81, Submitted on August 12, 2004; resubmitted on April 2, 2005; accepted on April 8,
lbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour
lbt lab tests t and Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour Research Instituteof Avicenna 4/23/2012 Why good prediction of poor response good prediction i of OHSS application appropriate
More informationThe association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age
Reproductive BioMedicine Online (2010) 21, 757 761 www.sciencedirect.com www.rbmonline.com ARTICLE The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Jeff G
More informationPrognosticating ovarian reserve by the new ovarian response prediction index
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Tak A et al. Int J Reprod Contracept Obstet Gynecol. 2018 Mar;7(3):1196-1200 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180917
More informationOvarian age-based stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in vitro fertilization
Ovarian age-based stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in vitro fertilization Norbert Gleicher, M.D., and David Barad, M.D. Center for Human
More informationOriginal Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer
Int J Clin Exp Med 2015;8(7):11327-11331 www.ijcem.com /ISSN:1940-5901/IJCEM0008838 Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and
More informationAntral follicle count as a predictor of ovarian response
Original article Antral follicle count as a predictor of ovarian response N. Lonegro a, N. Napoli a,*, R. Pesce b and C. Chacón a a Imaging Department, Hospital Italiano de Buenos Aires, Ciudad Autónoma
More informationIVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)
34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh
More informationCOMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL
COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL Nguyen Xuan Hoi1, Nguyen Manh Ha2 1 National Obstetrics and Gynecology Hospital, 2Hanoi Medical Unviversity
More informationInfertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF
Infertility in Women over 35 Alison Jacoby, MD Dept. of Ob/Gyn UCSF Learning Objectives Review the effect of age on fertility Fertility counseling for the patient >35 - timing - lifestyle - workup Fertility
More informationInternational Journal of Pharma and Bio Sciences ENDOCRINE MARKERS AND DECLINE IN REPRODUCTIVE POTENTIAL OF WOMEN ABSTRACT
Research Article Biochemistry International Journal of Pharma and Bio Sciences ISSN 0975-6299 ENDOCRINE MARKERS AND DECLINE IN REPRODUCTIVE POTENTIAL OF WOMEN BUSHRA FIZA *, 1, 2, RATI MATHUR 2, MAHEEP
More informationMinimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age
FERTILITY AND STERILITY VOL. 81, NO. 4, APRIL 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Minimal stimulation using recombinant
More informationPersonalizing ovarian stimulation for IVF
Personalizing ovarian stimulation for IVF Biljana Popovic-Todorovic MD,PhD Centre for Reproductive Medicine UZ Brussel QuickTime and are needed to see this picture. Controlled ovarian stimulation for IVF/ICSI
More informationFollicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation
Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation Aim: To determine whether a follicle-stimulating hormone (FSH)/luteinizing
More informationElena H. Yanushpolsky, M.D., a Shelley Hurwitz, Ph.D., b Eugene Tikh, B.S., c and Catherine Racowsky, Ph.D. a
FERTILITY AND STERILITY VOL. 80, NO. 1, JULY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Predictive usefulness of cycle
More informationAssociation of ovarian reserve with age, BMI and serum FSH level in subfertile women
409 ORIGINAL ARTICLE Association of ovarian reserve with age, BMI and serum FSH level in subfertile women Sarwat Jehan, 1 Sadiqa Syed 2 Abstract Objective: To examine the association of age, body mass
More informationEstradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success
DOI 10.1007/s13224-014-0515-6 ORIGINAL ARTICLE Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success Prasad Sudha Kumar Yogesh Singhal Megha Sharma Shashi Received: 27
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More information2017 United HealthCare Services, Inc.
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1143-4 Program Prior Authorization/Notification Medication Menopur (menotropins) * P&T Approval Date 8/2014, 5/2015, 5/2016, 5/2017
More informationResearch Article. Jayakrishnan Krishnakumar 1, Akansha Agarwal 1, Divya Nambiar 1, Shankar Radhakrishnan 2 *
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Krishnakumar J et al. Int J Reprod Contracept Obstet Gynecol. 2016 Aug;5(8):2762-2767 www.ijrcog.org pissn 2320-1770 eissn
More informationCORRELATIONS BETWEEN ANTI-MÜLLERIAN HORMONE, INHIBIN B, AND ACTIVIN A IN FOLLICULAR FLUID IN IVF/ICSI PATIENTS FOR ASSESSING
604 EU RO PE AN JOUR NAL OF MED I CAL RE SEARCH December 14, 2007 Eur J Med Res (2007) 12: 604-608 I. Holzapfel Publishers 2007 CORRELATIONS BETWEEN ANTI-MÜLLERIAN HORMONE, INHIBIN B, AND ACTIVIN A IN
More informationIVF treatment should not be postponed for patients with high basal FSH concentrations
Reproductive BioMedicine Online (2010) 21, 631 635 www.sciencedirect.com www.rbmonline.com SHORT COMMUNICATION IVF treatment should not be postponed for patients with high basal FSH concentrations Ettie
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationAnti-Mullerian hormone (AMH) as predictor of ovarian reserve
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Shembekar CA et al. Int J Reprod Contracept Obstet Gynecol. 2017 Sep;6(9):4006-4010 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174053
More informationInfertility Clinical Guideline
Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist
More informationHigh basal LH levels in combination with low basal FSH levels are associated with high success rates at assisted reproduction
Human Reproduction, Vol.24, No.11 pp. 2755 2759, 2009 Advanced Access publication on July 17, 2009 doi:10.1093/humrep/dep254 ORIGINAL ARTICLE Infertility High basal LH levels in combination with low basal
More informationE.R.Klinkert 1,3, F.J.M.Broekmans 1, C.W.N.Looman 2, J.D.F.Habbema 2 and E.R.te Velde 1
Human Reproduction Vol.20, No.3 pp. 611 615, 2005 Advance Access publication December 9, 2004. doi:10.1093/humrep/deh663 Expected poor responders on the basis of an antral follicle count do not benefit
More informationAntagonists in poor-responder patients
FERTILITY AND STERILITY VOL. 80, SUPPL. 1, JULY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Antagonists in poor-responder
More informationHum. Reprod. Advance Access published December 17, 2004 doi: /humrep/deh674
Human Reproduction Page 1 of 7 Hum. Reprod. Advance Access published December 17, 2004 doi:10.1093/humrep/deh674 Previous cycle cancellation due to poor follicular development as a predictor of ovarian
More informationIs it the seed or the soil? Arthur Leader, MD, FRCSC
The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events
More informationSingle and Repeated GnRH Agonist Stimulation Tests Compared With Basal Markers of Ovarian Reserve in the Prediction of Outcome in IVF
( C 2005) DOI: 10.1007/s10815-005-1495-3 Assisted Reproduction Single and Repeated GnRH Agonist Stimulation Tests Compared With Basal Markers of Ovarian Reserve in the Prediction of Outcome in IVF D. J.
More informationIN VITRO FERTILIZATION
FERTILITY AND STERILITY VOL. 82, NO. 4, OCTOBER 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION Prognostic
More informationA.J.Goverde 1,2,3, J.McDonnell 1, R.Schats 1, J.P.W.Vermeiden 1, R.Homburg 1 and C.B.Lambalk 1
Human Reproduction Vol.20, No.6 pp. 1573 1577, 2005 Advance Access publication March 3, 2005 doi:10.1093/humrep/deh827 Ovarian response to standard gonadotrophin stimulation for IVF is decreased not only
More informationIN VITRO FERTILIZATION
FERTILITY AND STERILITY VOL. 79, NO. 1, JANUARY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION
More informationA simple multivariate score could predict ovarian reserve, as well as pregnancy rate, in infertile women
A simple multivariate score could predict ovarian reserve, as well as pregnancy rate, in infertile women Johnny S. Younis, M.D., a,b Jimmy Jadaon, M.D., a Ido Izhaki, Ph.D., c Sami Haddad, M.D., a Orit
More informationArticle Evaluation of functional ovarian reserve in 60 patients
RBMOnline - Vol 7. No 2. 200 204 Reproductive BioMedicine Online; www.rbmonline.com/article/846 on web 12 June 2003 Article Evaluation of functional ovarian reserve in 60 patients Dr Giuseppe Loverro Giuseppe
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationin vitro fertilization
FERTILITY AND STERILITY VOL 69, NO. 6, JUNE 1998 Copyright (#1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Elevated levels of basal
More informationPoor & Hyper responders: what is the best approach?
Poor & Hyper responders: what is the best approach? A. La Marca ObGyn Dept University of Modena and Reggio Emilia Italy Center for Reproductive Medicine University Hospital of Modena Italy Criteria used
More informationEarly follicular anti-mullerian hormone as a predictor of ovarian response during ICSI cycles
Middle East Fertility Society Journal (2010) 15, 281 287 Middle East Fertility Society Middle East Fertility Society Journal www.mefsjournal.com www.sciencedirect.com ORIGINAL ARTICLE Early follicular
More informationIVF Performance of Women Who Have Fluctuating Early Follicular FSH Levels 1
CLINICAL ASSISTED REPRODUCTION IVF Performance of Women Who Have Fluctuating Early Follicular FSH Levels 1 A. LASS, 2,3 A. GERRARD, 2 N. ABUSHEIKHA, 2 F. AKAGBOSU, 2 and P. BRINSDEN 2 Submitted: April
More informationComparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve
Original Article Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve Sonal Panchal, Chaitanya Nagori Dr. Nagori s Institute for Infertility and IVF, Ellisbridge,
More informationAntral follicle count in clinical practice: analyzing clinical relevance
CONTROVERSY I Antral follicle count in clinical practice: analyzing clinical relevance Albert Hsu, M.D., Margaret Arny, Ph.D., Alexander B. Knee, M.S., Carrie Bell, M.D., Elizabeth Cook, Ph.D., Amy L.
More information- Meta. : (rfsh); (ufsh); (IVF); : R711.6 : A : X(2015) : hmg( FSH LH) [ufsh, (ufsh-p) (ufsh-hp)] (rfsh) [1] 80, rfsh, 90, :
35 2 Vol.35 No.2 2015 2 Feb. 2015 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2015.02.0099 E-mail: randc_journal@163.com (FSH) - Meta FSH ( 400010) : (IVF) (ICSI) (rfsh) (ufsh) (COS) : PubMed
More informationChanges in measured endometrial thickness predict in vitro fertilization success
Changes in measured endometrial thickness predict in vitro fertilization success Grant D. E. McWilliams, D.O., a and John L. Frattarelli, M.D. b a Tripler Army Medical Center, Honolulu, Hawaii; and b Reproductive
More informationInterpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used
Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara
More informationTimur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.
FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating
More informationQuantitative analysis of antral follicle number and size: a comparison of two-dimensional and automated three-dimensional ultrasound techniques
Ultrasound Obstet Gynecol 2010; 35: 354 360 Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.7505 Quantitative analysis of antral follicle number and size: a comparison
More informationJMSCR Vol 06 Issue 09 Page September 2018
www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i9.53 Role of Anti-Mullerian Hormone
More informationOvarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy
Ovarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy M.E. Coccia, F. Cammilli, L. Ginocchini, F. Borruto* and F. Rizzello Dept Gynaecology Perinatology and Human
More informationProgesterone and clinical outcomes
Synchronization of Slowly Developing Embryos Restores Implantation Success Richard T. Scott, Jr, MD, HCLD Clinical and Scientific Director, Reproductive Medicine Associates of New Jersey Professor and
More informationVanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D.
Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol
More informationCorrelation of the Day 3 FSH/LH Ratio and LH Concentration in Predicting IVF Outcome
Original Article Correlation of the Day 3 FSH/LH Ratio and LH Concentration in Predicting IVF Outcome Sudha Prasad 1*, Teena Gupta 1, Aabha Divya 2 1- IVF and Reproductive Biology Centre, Department of
More informationIn Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome
Original Article Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome Maryam Eftekhar, M.D. 1, Razieh Deghani Firoozabadi,
More informationAdvanced age, poor responders and the role of LH supplementation. C. Alviggi University Federico II, Naples, Italy
Advanced age, poor responders and the role of LH supplementation C. Alviggi University Federico II, Naples, Italy LH serum level (IU/L) 20.0 15.0 10.0 5.0 0.0 LH levels during spontaneous and stimulated
More informationOvarian response in three consecutive in vitro fertilization cycles
FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Ovarian response in
More informationAndrogen supplementation in women with low functional ovarian reserve
Androgen supplementation in women with low functional ovarian reserve Norbert Gleicher, MD Medical Director and Chief Scientist, Center For Human Reproduction, New York, NY President, Foundation For Reproductive
More informationPredictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older
Reprod Med Biol (2009) 8:145 149 DOI 10.1007/s12522-009-0023-z ORIGINAL ARTICLE Predictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older Akihisa
More informationEvaluation of ovarian response prediction according to age and serum AMH levels in IVF cycles: a retrospective analysis
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Pillai SM et al. Int J Reprod Contracept Obstet Gynecol. 2017 Aug;6(8):3306-3310 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20173190
More informationComparison of single versus double intra uterine insemination
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Pathak B. Int J Reprod Contracept Obstet Gynecol. 2017 Dec;6(12):5277-5281 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20175091
More informationInfertility: A Generalist s Perspective
Infertility: A Generalist s Perspective Learning Objectives Fertility and Lifestyle: Patient education Describe the basic infertility workup Basic treatment strategies unexplained Heather Huddleston, MD
More informationThree-dimensional ultrasound improves the interobserver reliability of antral follicle counts and facilitates increased clinical work flow
Ultrasound Obstet Gynecol 28; 31: 439 444 Published online 1 March 28 in Wiley InterScience (www.interscience.wiley.com). DOI: 1.12/uog.531 Three-dimensional ultrasound improves the interobserver reliability
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,
More informationUnderstanding Infertility, Evaluations, and Treatment Options
Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly
More informationQuestions. Ultrasound markers of ovarian reserve Modena April 18-19, Your choice is.. Impact study: stop OR tests or Soft catheters??
Ultrasound markers of ovarian reserve Modena April 18-19, 2008 Frank J Broekmans Reproductive Medicine UMC Utrecht Impact study: stop OR tests or Soft catheters?? Stop OR screening, cost reduction 21 euro
More informationAnti-Mullerian Hormone as a Predictive Factor in Assisted Reproductive Technique of Polycystic Ovary Syndrome Patients
ORIGINAL REPORT Anti-Mullerian Hormone as a Predictive Factor in Assisted Reproductive Technique of Polycystic Ovary Syndrome Patients Ashraf Aleyasin, Marzie Aghahoseini, Sara Mokhtar, and Parvin Fallahi
More informationGn-RH Agonist Challenge Test for Predicting Ovarian Reserve in Short Protocol Cycles
J Obstet Gynecol lnd Vol. 54, No.1: January/February 2004 Pg 51-55 Gn-RH Agonist Challenge Test for Predicting Ovarian Reserve in Short Protocol Cycles Ocal Pelin, Cepni Ismail, Akbas Hande, Idil Mehmet,
More informationAMH CUT-OFF VALUES FOR PREDICTING OVARIAN RESPONSE IN IVF. Nguyễn Xuân Hợi, MD, PhD Hoàng Văn Hùng MsC, MD
AMH CUT-OFF VALUES FOR PREDICTING OVARIAN RESPONSE IN IVF Nguyễn Xuân Hợi, MD, PhD Hoàng Văn Hùng MsC, MD INTRODUCTION Ovarian stimulation is an important process in IVF treatment, aiming at obtain a number
More informationSummary
Summary 118 This thesis is focused on the background of elevated levels of FSH in the early follicular phase of women with regular menstrual cycles. In the introduction (chapter 1) we describe the characteristics
More informationAntral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
BJOG: an International Journal of Obstetrics and Gynaecology October 2005, Vol. 112, pp. 1384 1390 DOI: 10.1111/j.1471-0528.2005.00670.x Antral follicle count, anti-mullerian hormone and inhibin B: predictors
More informationArticle Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?
RBMOnline - Vol 16. No 5. 2008 664-670 Reproductive BioMedicine Online; www.rbmonline.com/article/3179 on web 11 March 2007 Article Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality
More informationLOW COST PROTOCOL VERSUS SHORT PROTOCOL FOR CONTROLLED OVARIAN STIMULATION IN ICSI TRIALS
LOW COST PROTOCOL VERSUS SHORT PROTOCOL FOR CONTROLLED OVARIAN STIMULATION IN ICSI TRIALS Salem H. H. '; Nassar A. M.,&l ; Askalany N. A. ', Kassem K. 1&4 Department of Obstetrics and Gynecology Al Azhar
More informationNatural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles
Natural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles Mauro Schimberni, M.D., a Francesco Morgia, B.S., a Julio Colabianchi, M.D., a Annalise Giallonardo,
More information% Oocyte Donation Pregnancyes (days 3)
Ovulation induction in oocyte donors Roma- September 2007 Dr. José Remohí Dr. Carmen Rubio Dr. Amparo Mercader Dr. Pilar Alama Dr. Marco Melo Evolution of oocyte donation cycles 1500 1500 1000 58% 661
More informationBest practices of ASRM and ESHRE
Best practices of ASRM and ESHRE Late submission Cortina d Ampezzo, Italy 1-3 March 2012 A joint meeting between the American Society for Reproductive Medicine and the European Society of Human Reproduction
More informationAntral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment
Human Reproduction Vol.20, No.6 pp. 1647 1654, 2005 Advance Access publication February 25, 2005 doi:10.1093/humrep/deh833 Antral follicle count and FSH concentration after clomiphene citrate challenge
More informationSerum anti-müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles
Human Reproduction Vol.23, No.1 pp. 160 167, 2008 Advance Access publication on November 13, 2007 doi:10.1093/humrep/dem254 Serum anti-müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation
More informationSerum Estradiol Level as a Predictor of Ovarian Response and Pregnancy Outcome During Controlled Ovarian Hyperstimulation in Women from Gaza Strip
J MEDICINE 2013; 14 : 52-56 Serum Estradiol Level as a Predictor of Ovarian Response and Pregnancy Outcome During Controlled Ovarian Hyperstimulation in Women from Gaza Strip MAGED M. YASSIN, 1 MOHAMMED
More informationManish Banker. Declared receipt of grants; member of a company advisory board, board of director or similar group
Manish Banker Nova IVI Fertility Pulse Women's Hospital Gujarat, India Declared receipt of grants; member of a company advisory board, board of director or similar group The Indian point of view Manish
More informationGnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF/ICSI
ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2011.38.4.228 pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2011;38(4):228-233 GnRH antagonist multiple dose protocol with oral contraceptive pill
More informationThe Significance of Low Anti-Müllerian Hormone Levels in Young Women Undergoing in Vitro Fertilization
The Significance of Low Anti-Müllerian Hormone Levels in Young Women Undergoing in Vitro Fertilization Caitlin Haswell, M.D., Estil Strawn, Jr., M.D., Aniko Szabo, Ph.D., Joseph Davis, D.O., and Kate D.
More information(Predictive. value) Soheila Ansaripour Fellowship of infertility Ai Avicena Research In
Ovarian Rese erve Lab Tests In (Predictive IVF value) Soheila Ansaripour Fellowship of infertility Ai Avicena Research In nstitute t Case Presentation 29 y/o,primary inf 1.5yr, Hx of irregular menses (
More informationAims of this talk. Evaluation & investigation. Basic treatments/options including ovulation induction & Intra uterine Insemination
Basic treatments/options including ovulation induction & Intra uterine Insemination Karen Woodcock Clinical Nurse Specialist/ Nurse Manager Fertility & Assisted Conception Unit Countess of Chester NHS
More informationSTIMULATION AND OVULATION TRIGGERING
STIMULATION AND OVULATION TRIGGERING Professor IOANNIS E. MESSINIS MD, PhD (Aberdeen, UK), FRCOG (UK) Department of Obs/Gynae University of Thessaly Larissa, GREECE DISCLOSURE Nothing to disclose Learning
More informationFollicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET
J Hum Genet (2006) 51:665 670 DOI 10.1007/s10038-006-0005-5 ORIGINAL ARTICLE Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET
More informationThe emergence of Personalized Medicine protocols for IVF.
Individualising IVF: Introduction to the POSEIDON Concept Introduction The emergence of Personalized Medicine protocols for IVF. Differences between patients: age, ovarian reserve, BMI or presence of ovarian
More informationA prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF
FVV IN OBGYN, 2012, 4 (2): 82-87 Original paper A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF S. GORDTS,
More informationPrognostic value of day 3 estradiol on in vitro fertilization outcome*
FERTILITY AND STERILITY Vol. 64, No.6, December 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Prognostic value of day 3 estradiol on in vitro fertilization
More informationIVF-ICSI outcome in relation to the antral follicle count. Study population and amount of treatments.
Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic ovaries Jan Holte, M.D., Ph.D., a,b Thomas Brodin,
More informationEffect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial
FULL PROJECT TITLE: Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial (STimulation Resulting in Embryonic Aneuploidy using Menopur (STREAM)
More informationEvaluation of basal estradiol levels in assisted reproductive technology cycles
FERTILITY AND STERILITY VOL. 74, NO. 3, SEPTEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Evaluation of basal
More informationAre all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes?
Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes? Andrea Weghofer Foundation for Reproductive Medicine 2017 New York, November 16-19 Conflict of interest No relevant financial
More informationEvidence-based treatment of POR and POF. Ovarian Club X and CoGEN in Asia December 16-17, 2017 Hong Kong
Evidence-based treatment of POR and POF Norbert Gleicher, MD Medical Director and Chief Scientist, Center For Human Reproduction, New York, NY Presi d ent, Foundation For Reproductive Medicine, New York,
More informationLuteal phase rescue after GnRHa triggering Progesterone and Estradiol
Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective
More informationA multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of
A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of Endometrioma and deep infiltrating endometriosis Professor C. Chapron and the Group
More informationArticle Relevance of basal serum FSH to IVF outcome varies with patient age
RBMOnline - Vol 17. No 1. 2008 10-19 Reproductive BioMedicine Online; www.rbmonline.com/article/3144 on web 16 May 2008 Article Relevance of basal serum FSH to IVF outcome varies with patient age Dr Luca
More information2013 Sep.; 24(3):
Journal of Reproduction & Contraception doi: 10.7669/j.issn.1001-7844.2013.03.0159 2013 Sep.; 24(3):159-172 E-mail: randc_journal@163.com Comparison of the Effects and Safety of Mild Ovarian Stimulation
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationDoes previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?
J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation
More informationHow to supplement hypo-androgenic women correctly
How to supplement hypo-androgenic women correctly Norbert Gleicher, MD Medical Director and Chief Scientist, Center For Human Reproduction, New York, NY President, Foundation For Reproductive Medicine,
More informationThree-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age
FERTILITY AND STERILITY VOL. 79, NO. 1, JANUARY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Three-dimensional
More information